Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000805928-21-000072
Filing Date
2021-03-31
Accepted
2021-03-31 16:06:36
Documents
12
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A axgn_proxyx2020.htm DEF 14A 1159765
2 GRAPHIC axogeninc1024_1c111.jpg GRAPHIC 108059
3 GRAPHIC axogeninc1024_1c211.jpg GRAPHIC 144747
4 GRAPHIC axogeninc1024_2c121.jpg GRAPHIC 78038
5 GRAPHIC axogeninc1024_2c221.jpg GRAPHIC 103295
6 GRAPHIC image1.jpg GRAPHIC 21273
7 GRAPHIC image2.jpg GRAPHIC 20270
8 GRAPHIC image3.jpg GRAPHIC 8353
9 GRAPHIC image_01.jpg GRAPHIC 48557
10 GRAPHIC image_11.jpg GRAPHIC 10908
11 GRAPHIC image_21.jpg GRAPHIC 44886
12 GRAPHIC image_91.jpg GRAPHIC 128
  Complete submission text file 0000805928-21-000072.txt   1967290
Mailing Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615
Business Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615 (386) 462-6817
Axogen, Inc. (Filer) CIK: 0000805928 (see all company filings)

EIN.: 411301878 | State of Incorp.: MN | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36046 | Film No.: 21793314
SIC: 3845 Electromedical & Electrotherapeutic Apparatus